Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
GRIA2 Biologics Sequence Review Report 2026: Glutamate receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIA1 Biologics Sequence Review Report 2026: Glutamate receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GRIA3 Biologics Sequence Review Report 2026: Glutamate receptor 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GRIA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GLRA3 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GLRB Biologics Sequence Review Report 2026: Glycine receptor subunit beta Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GLRA1 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GLRA2 Biologics Sequence Review Report 2026: Glycine receptor subunit alpha-2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GLRA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRR3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit rho-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GALR1 Biologics Sequence Review Report 2026: Galanin receptor type 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GALR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GALR3 Biologics Sequence Review Report 2026: Galanin receptor type 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GALR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GFRA1 Biologics Sequence Review Report 2026: GDNF family receptor alpha-1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GFRA1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GABRB3 Biologics Sequence Review Report 2026: Gamma-aminobutyric acid receptor subunit beta-3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of GABRB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
10
11
12
13
14
>>
1670
>